Close Menu

Microarrays & Multiplexing

News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.

Quotient said that the revenue increase was driven by higher direct product sales, as well as sales to original equipment manufacturing customers.

The company also received a contract from the Henry M. Jackson Foundation for a separate sepsis test.

Nationwide Labs will use the PathogenDx array system for rapid strain identification of skin and foot fungi.

The company — develops tests for the early detection of cancer and other diseases in whole blood — is targeting C$3.7 million in a private placement financing round.

The funding will be used to support clinical validation and expand market access for the firm's endometriosis diagnostic test.